Internal Medicine, Gastroenterology · Cleveland, OH
NPI
1497712814
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (800) 223-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
574 services
Medicare patients, 2024
199
Average age 68
Drug cost, 2024
$1.4M
302 prescriptions
Company payments, 2025
$397
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bo Shen was code 99214 (office e&m - established), 167 times for 106 patients. In total Bo Shen billed 574 services in 49 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 167 | 106 | $114.40 | $19K |
| 45380 Lower GI Endoscopy - Other | Facility | 55 | 54 | $122.52 | $6,738 |
| 43239 Upper GI Endoscopy | Facility | 41 | 40 | $87.50 | $3,587 |
| 99204 Office E&M - New | Office | 41 | 41 | $152.09 | $6,236 |
| 44799 Digestive/Gastrointestinal | Facility | 30 | 22 | $211.36 | $6,341 |
| 44386 Digestive/Gastrointestinal | Facility | 27 | 25 | $66.27 | $1,789 |
| 99443 Telephone Services | Office | 24 | 17 | $117.33 | $2,816 |
| 99215 Office E&M - Established | Office | 20 | 20 | $144.39 | $2,888 |
By year: 2022 $70K for 531 services; 2023 $57K for 462 services; 2024 $70K for 574 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bo Shen prescribed most often to Medicare patients was Stelara (Ustekinumab), with 34 prescriptions and refills. In total Bo Shen wrote 302 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 34 | 46 | Under 11 | $861K |
| Mesalamine Generic | 32 | 38 | Under 11 | $8,089 |
| Tinidazole Generic | 31 | 31 | Under 11 | $6,262 |
| Rinvoq Upadacitinib | 24 | 24 | Under 11 | $154K |
| Entyvio Vedolizumab | 20 | 27 | Under 11 | $169K |
| Vancomycin Hcl Generic | 20 | 20 | Under 11 | $5,867 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 14 | 14 | Under 11 | $397 |
| Sodium Chloride 0.9 % Sodium Chloride | 11 | 11 | Under 11 | $20.12 |
Brand drugs: 132 claims; generic drugs: 170 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bo Shen $397 ($397 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $161.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.